Tailoring antitubercular therapy in a critically ill patient with abdominal tuberculosis
Abstract
Abdominal tuberculosis may present acutely as peritonitis or intestinal perforation, which might need immediate surgical intervention and postoperative intensive care. Even in rifampicin-sensitive tuberculosis, standard first-line oral antitubercular therapy might be ineffective due to the unreliable gastrointestinal absorption and altered pharmacokinetics. We report a case of a young woman with abdominal tuberculosis and multiple ileal perforations who required intensive care following emergency laparotomy. We used an initial antitubercular treatment with the combination of intravenous amikacin, linezolid and levofloxacin until intestinal function recovered. She was then transitioned to standard oral therapy with rifampicin, isoniazid, pyrazinamide and ethambutol, achieving full recovery. This case highlights the value of short-term parenteral antitubercular regimens as a bridge in critically ill patients with gastrointestinal compromise, underscoring the role of pharmacokinetic considerations and multidisciplinary care.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.